INTRODUCTION AND OBJECTIVES: Mortality of Radical cystectomy (RC) differs in the literature from as low as 2.3% for a 90-day mortality in a single institution, to as high as 7.9% for a prospective multi-institutional series or 5% for a retrospective review of administrative population-based database. 90-day mortality rate of RC in a nation-wide population-based study has not been explored.
INTRODUCTION AND OBJECTIVES: Patients undergoing major operations often become catabolic and have muscle break down. Patients undergoing cystectomy fall into this category and the catabolism postoperatively frequently leads to poor outcomes. We sought to detail the testosterone levels in patients preoperatively (preop) and postoperatively (POD) to study the potential for future intervention with anabolic steroids and which patients might benefit the most from such an intervention.
METHODS: Patients were prospectively enrolled in the study. Blood was collected preop, POD1, POD3 and POD14. Testosterone was analyzed with electrochemiluminescence immunoassay on Roche Cobas 8000 in the clinical laboratory. A high affinity monoclonal antibody specifically directed against testosterone was used. Testosterone was measured in ng/dl. Testosterone <300 ng/dl was considered hypogonadal. Poor recovery was considered a complication greater than Clavien grade 2 or a readmission. Frailty was determined by preoperative G8 geriatric assessment. Chi-squared and logistic regression were used where appropriate.
RESULTS: Median age was 70.5. There were 40 males and 6 females. In males: the mean preop testosterone was 517, POD1-280, POD3-234, POD14-372. In females: the mean preop testosterone was 14, POD1-25, POD3-21, POD14-14. Of the males, 22% were hypogonadal preop, 61% POD1, 68% on POD3, 39% on POD14. Higher testosterone level preop, higher POD14 and change in testosterone level as a continuous variable were not associated with a greater chance of poor or ideal recovery (p[0.12, p[0.13, and p[0.07, respectively . Of those who were considered frail (n[7), 70% were hypogonadal by POD 3 (p<0.05). Patients with preoperative hypogonadism were significantly associated with poor recovery (p<0.05).
CONCLUSIONS: In men undergoing cystectomy, preoperative frailty as well as hypogonadism are significant predictors of poor recovery. Underlying catabolism from surgery may be able to be predicted preoperatively and be proactively treated in order to attain ideal recovery for patients undergoing cystectomy. Further exploration is warranted in improving surgical outcomes with anabolic steroid supplementation in those at highest risk of poor recovery.
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PD57-12 ROLE OF ROUTINE BIOPSY AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
Ronald Kool*, Adnan Adnan El-Achkar, Gautier Marq, Leonardo Monteiro, Marie Vanhuyse, Armen Aprikian, Simon Tanguay, Fabio Cury, Luis Souhami, Wassim Kassouf, Montreal, Canada INTRODUCTION AND OBJECTIVES: Radiation-based therapy (RT) has emerged as a suitable alternative to radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC) patients. According to most guidelines a biopsy after RT is mandatory to rule out persistent or residual disease within 3 months post treatment. Our objective was to analyze the performance of biopsy to assess response post RT.
METHODS: In this retrospective study, we included all patients undergoing curative-intent RT for MIBC at our institution between 2003 and 2017. Results from cross-sectional imaging, cystoscopy, urine cytology and biopsy was collected. A descriptive analysis was performed. Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e1027
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